The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real ...

Vaxitek HVT+IBD+H5 integrates COBRA technology to address the ongoing viral evolution challenges of avian influenza, as well ...

Unconfirmed reports suggest that a popular flu vaccine educational campaign has come to an end.

Biopharmas and global agencies are now prioritizing initiatives and innovations to drive speed across product development ...

John Arena, interim president of global pharma services at Cencora, discusses how new technologies are shortening timelines.

John Arena, interim president of global pharma services at Cencora, discusses the importance of engaging with partners as ...

According to ZERO Prostate Cancer, Novartis has committed $7.5 million to the initiative.

Traditional approaches to HCP segmentation are no longer sufficient. The challenge now is to maintain personalization at ...

The campaign is based on the results of a survey that reveals the experiences of patients and caregivers in their communities ...

Valencia will seek to leverage the investment as well as Surek’s leadership experience to drive commercialization of its ...

Led by Bosch Ventures, Applyo Jena’s Series A funding seeks to accelerate the development and commercialization of its ...

Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a ...